Home › NDC Lookup › Ingredients › Adalimumab-Atto
📦 NDC / package directory — not a drug information page

Adalimumab-Atto NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Adalimumab-Atto products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

30
Package NDCs
36
Products
36
Active listings
0
Discontinued
3
Labelers
6
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
ADALIMUMAB 40 mg/.4mL 12
ADALIMUMAB 80 mg/.8mL 8
ADALIMUMAB 20 mg/.2mL 6
ADALIMUMAB 40 mg/.8mL 6
ADALIMUMAB 20 mg/.4mL 2
ADALIMUMAB 10 mg/.2mL 2
By dosage form
INJECTION 36
Top labelers
Amgen, Inc 18
Amgen USA Inc. 10
Nuvaila Limited 8

Browse records — 36 products

Drug / product Billing NDC NADAC / unit Status
AMJEVITA adalimumab-atto 20 mg/.4mL INJECTION Amgen, · NDC 55513-0411-01 · 1 SYRINGE in 1 CARTON (55513-411-01) / .4 mL in 1 SYRINGE 55513-0411-01 — On market View →
AMJEVITA adalimumab-atto 10 mg/.2mL INJECTION Amgen, · NDC 55513-0413-01 · 1 SYRINGE in 1 CARTON (55513-413-01) / .2 mL in 1 SYRINGE 55513-0413-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Amgen, · NDC 55513-0481-01 · 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE 55513-0481-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen, · NDC 55513-0479-01 · 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE 55513-0479-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Amgen · NDC 72511-0399-01 · 1 SYRINGE in 1 CARTON (72511-399-01) / .2 mL in 1 SYRINGE 72511-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.8mL INJECTION Amgen · NDC 72511-0400-01 · 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE 72511-0400-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen · NDC 72511-0479-02 · 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE 72511-0479-02 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen · NDC 72511-0482-01 · 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE 72511-0482-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0482-01 · 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE 84612-0482-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen, · NDC 55513-0482-01 · 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE 55513-0482-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Amgen, · NDC 55513-0399-01 · 1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE 55513-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.8mL INJECTION Amgen, · NDC 55513-0400-01 · 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE 55513-0400-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.8mL INJECTION Amgen, · NDC 55513-0410-01 · 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE 55513-0410-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Amgen · NDC 72511-0481-02 · 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE 72511-0481-02 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Nuvaila · NDC 84612-0399-01 · 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE 84612-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0479-01 · 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE 84612-0479-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Nuvaila · NDC 84612-0481-01 · 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE 84612-0481-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Amgen, · NDC 55513-0480-01 · 1 SYRINGE in 1 CARTON (55513-480-01) / .8 mL in 1 SYRINGE 55513-0480-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen · NDC 72511-0479-02 · 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE 72511-0479-02 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Nuvaila · NDC 84612-0399-01 · 1 SYRINGE in 1 CARTON (84612-399-01) / .2 mL in 1 SYRINGE 84612-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0482-01 · 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE 84612-0482-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.2mL INJECTION Amgen, · NDC 55513-0399-01 · 1 SYRINGE in 1 CARTON (55513-399-01) / .2 mL in 1 SYRINGE 55513-0399-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Nuvaila · NDC 84612-0479-01 · 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE 84612-0479-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen, · NDC 55513-0482-01 · 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE 55513-0482-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen · NDC 72511-0482-01 · 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE 72511-0482-01 — On market View →
AMJEVITA adalimumab-atto 20 mg/.4mL INJECTION Amgen, · NDC 55513-0411-01 · 1 SYRINGE in 1 CARTON (55513-411-01) / .4 mL in 1 SYRINGE 55513-0411-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Amgen, · NDC 55513-0480-01 · 1 SYRINGE in 1 CARTON (55513-480-01) / .8 mL in 1 SYRINGE 55513-0480-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.8mL INJECTION Amgen, · NDC 55513-0400-01 · 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE 55513-0400-01 — On market View →
AMJEVITA adalimumab-atto 40 mg/.4mL INJECTION Amgen, · NDC 55513-0479-01 · 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE 55513-0479-01 — On market View →
AMJEVITA adalimumab-atto 80 mg/.8mL INJECTION Amgen, · NDC 55513-0481-01 · 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE 55513-0481-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.